![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00010608 |
The purpose of this study is to evaluate the effectiveness of meditation in preventing of atherosclerotic cardiovascular disease (CVD) in postmenopausal, older African American women.
Condition | Intervention | Phase |
---|---|---|
Cardiovascular Diseases |
Procedure: Meditation Behavioral: Health Education |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind |
Official Title: | Clinical Trial of Meditation for Cardiovascular Disease in Older Black Women |
Estimated Enrollment: | 196 |
Older African American women suffer from disproportionately high rates of cardiovascular (CVD) morbidity and mortality compared to white Americans. Numerous controlled studies suggest that this disparity is associated with chronic psychosocial and environmental stress. Research indicates that Transcendental Meditation (TM) may result in significant improvements in CVD risk factors in this high risk population.
Participants in this study will be randomly assigned to either active stress reduction with TM or health education control, both in addition to usual medical care, for 12 months. The primary outcome will be carotid artery atherosclerosis (IMT) measured non-invasively by quantitative B-mode ultrasonography. Secondary measures will include traditional CVD risk factors (blood pressure, serum glucose and insulin levels, obesity, and sedentary lifestyle), stress-related neurohormones (catecholamine metabolite and cortisol), psychosocial stress, and quality of life. The results of this trial will yield valuable new knowledge for the prevention of CVD through a CAM intervention in high risk older African American women.
Ages Eligible for Study: | 60 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
United States, District of Columbia | |
Howard University Medical Center | |
Washington, DC, District of Columbia, United States | |
United States, Georgia | |
Morehouse School of Medicine | |
Atlanta, Georgia, United States | |
United States, Iowa | |
Maharishi University of Management | |
Fairfield, Iowa, United States, 52557 |
Principal Investigator: | Robert H. Schneider, MD | Center for Health and Aging Studies |
Study ID Numbers: | P50 AT000082-01P2, P50AT000082-01, P50AT000082-02 |
Study First Received: | February 2, 2001 |
Last Updated: | August 17, 2006 |
ClinicalTrials.gov Identifier: | NCT00010608 |
Health Authority: | United States: Federal Government |
CVD |
Cardiovascular Diseases |